Glenmark Pharmaceuticals Statistics
Total Valuation
Glenmark Pharmaceuticals has a market cap or net worth of INR 480.48 billion. The enterprise value is 476.19 billion.
Market Cap | 480.48B |
Enterprise Value | 476.19B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
Earnings Date | Oct 31, 2024 |
Ex-Dividend Date | Sep 16, 2024 |
Share Statistics
Glenmark Pharmaceuticals has 282.19 million shares outstanding. The number of shares has decreased by -0.07% in one year.
Shares Outstanding | 282.19M |
Shares Change (YoY) | -0.07% |
Shares Change (QoQ) | -0.02% |
Owned by Insiders (%) | 3.79% |
Owned by Institutions (%) | 34.78% |
Float | 138.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 31.91 |
PS Ratio | 3.73 |
PB Ratio | 6.12 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -36.31 |
EV / Sales | 3.70 |
EV / EBITDA | 20.31 |
EV / EBIT | 29.24 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 15.69 |
Debt / EBITDA | 0.53 |
Debt / FCF | n/a |
Interest Coverage | 3.67 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 8.65% |
Revenue Per Employee | 8.58M |
Profits Per Employee | -874,865 |
Employee Count | 14,989 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +114.73% in the last 52 weeks. The beta is 0.91, so Glenmark Pharmaceuticals's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | +114.73% |
50-Day Moving Average | 1,486.83 |
200-Day Moving Average | 1,089.73 |
Relative Strength Index (RSI) | 70.56 |
Average Volume (20 Days) | 1,299,164 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Glenmark Pharmaceuticals had revenue of INR 128.61 billion and -13.11 billion in losses. Loss per share was -46.48.
Revenue | 128.61B |
Gross Profit | 85.26B |
Operating Income | 16.29B |
Pretax Income | 3.47B |
Net Income | -13.11B |
EBITDA | 23.44B |
EBIT | 16.29B |
Loss Per Share | -46.48 |
Balance Sheet
The company has 16.59 billion in cash and 12.31 billion in debt, giving a net cash position of 4.29 billion or 15.19 per share.
Cash & Cash Equivalents | 16.59B |
Total Debt | 12.31B |
Net Cash | 4.29B |
Net Cash Per Share | 15.19 |
Equity (Book Value) | 78.48B |
Book Value Per Share | 278.09 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 66.29%, with operating and profit margins of 12.66% and -10.20%.
Gross Margin | 66.29% |
Operating Margin | 12.66% |
Pretax Margin | 2.70% |
Profit Margin | -10.20% |
EBITDA Margin | 18.23% |
EBIT Margin | 12.66% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.15%.
Dividend Per Share | 2.50 |
Dividend Yield | 0.15% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.07% |
Shareholder Yield | 0.21% |
Earnings Yield | -2.73% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.
Last Split Date | Sep 10, 2007 |
Split Type | Forward |
Split Ratio | 2 |